SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-06-000041
Filing Date
2006-11-14
Accepted
2006-11-14 15:09:30
Documents
6
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 BIOSANTE 10Q FOR QUARTER 3 2006 biosanteq32006.htm 10-Q 661035
2 U OF C AGREEMENT 4TH AMENDMENT uofcagreement.htm EX-10.1 68458
3 CEO 302 CERTIFICATION exhibit31w1.htm EX-31.1 11356
4 CFO 302 CERTIFICATION exhibit31w2.htm EX-31.2 12116
5 CEO 906 CERTIFICATION exhibit32w1.htm EX-32.1 4570
6 CFO 906 CERTIFICATION exhibit32w2.htm EX-32.2 5104
  Complete submission text file 0001023024-06-000041.txt   764169
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 061214337
SIC: 2836 Biological Products, (No Diagnostic Substances)